Product News and Recalls

Anthrax Victim’s Family to Receive $2.5 Million Settlement from Government

The Associated Press reported today that the United States government has agreed to pay $2.5 million to settle a case brought by the family of Robert Stevens, who died after being exposed to anthrax in 2001. Stevens was one of four people who died during the attacks. Seventeen other people were exposed to anthrax and became sick. According to ABC news, many still have lingering health problems attributed to the anthrax. Several other lawsuits were filed, but most have been ...

continue reading...

NHTSA investigating Chevy Volt after post-crash fire

The National Highway Traffic Safety Administration (NHTSA) announced on Friday that it is opening a formal safety defect investigation into the Chevy Volt.

After conducting a standard crash test on the electric car, the NHTSA found that the vehicle’s battery was damaged and the coolant line was ruptured. A fire broke out a few weeks later and is being blamed on the battery. Follow-up tests demonstrated similar results.

Although no formal recall has ...

continue reading...

Merck Pleads Guilty to Illegally Selling Vioxx

Vioxx Settlement

The New York Times reported today that Merck pled guilty to “illegally introducing a drug into interstate commerce” for its sale of Vioxx. As part of the plea, Merck entered into a larger settlement in which it agreed to pay $950 million. According to the New York Times, Merck will pay a $321 million criminal fine, while $628 million will go to the federal government and state medicaid agencies to ...

continue reading...

Bloomberg reports over 10,000 women have sued Bayer for Yaz blood clots and other injuries

Yaz blood clot risk main concern

Bloomberg news published an extensive article today, discussing internal emails from Bayer that it obtained. Bloomberg reports that over 10,000 women have sued Bayer claiming they were injured by Yaz or Yasmin and not warned of increased risks associated with those drugs. Bloomberg further reported that internal emails show that Bayer marketed Yaz and Yasmin for uses not approved by the FDA. This type of ...

continue reading...

Seven Studies now Show Drospirenone (Yaz/Yasmin/Beyaz) increase risk of clots

The most recent independent study was published today in the Canadian Medical Journal

The Canadian Medical Journal published an article today by Dr. Gronich from the Department of Community Medicine and Epidemiology, looking at approximately 330,000 women taking various birth control pills. Overall, they found that drospirenone, an ingredient in Yaz, Yasmin, Ocella, and Beyaz, had a 65% increased risk of causing blood clots when compared more established birth control pills, ...

continue reading...

FDA to Consider new Yaz/Yasmin Warnings Next Month

December 8 Meeting Scheduled to Discuss 6 Studies Showing Increased Risk of Blood Clots

The FDA will hold hearings next month to consider the risks of blood clots associated with Yaz, Yasmin, Ocella, and Beyaz. Although approximately six studies now show an increased risk, the FDA has not yet determined whether to officially update the warnings on these pills. The agency is widely expected to make a decision at or shortly after ...

continue reading...
Page 323 of 333 «...300310320321322323324325...»